Pharmaceutical Market Europe • October 2024 • 3
COMMENT
This month, as part of our Women in Pharma series, I spoke to Ulrike Graefe-Mody, global head of retinal health at Boehringer Ingelheim, about her career path and how female representation in the industry has changed over the past two decades. As Ulrike says: “I would be nothing without my high-performing, cross-functional leadership team. Having the right mix of people is absolutely key to me.” Read more on page 16.
Danny Buckland’s article looks at driving launch excellence in a volatile sector through precision, planning and creativity. As he says: “Sticking to routines and mechanisms that served well over previous generations of launch will not insulate against the fierce failure rate of the current, volatile climate infused with the often competing interests of patients, HCPs and healthcare systems set against the constant drum beat of digital change.” Turn to page 28 to find out more.
This year, ESMO’s flagship annual congress was held in Barcelona, where it offered new markers of hope for the future of oncology. Susanne Bobadilla from VML Health writes: “The meeting provided the usual mix of breakthrough science, landmark data and the promise of better outcomes in a range of cancers. But, aside from the science, the most interesting trend from a marketing perspective was the clear change of emphasis in the language of cancer, with companies across the space reframing the narrative to focus on ‘living’ rather than just ‘surviving’.” Read more about this exciting congress on page 20.
This month we have a new column from the co-chairs of Communiqué, Catherine Devaney and Neil Flash. Catherine kicks off the new series with a look at how the role of innovation will shape the future of health communications and next month Neil will look at the rising importance of demonstrating impact in pharma communications. Turn to page 15 to find out more.
Next month, our November issue looks at improving patient pathways through health equity and accessibility. If you would like to make your voice heard on this topic, please get in touch at sales@pmlive.com
And don’t forget to book your tickets for the PMEAs, taking place at a black tie event in London on 21 November. Email ddevadiga@pmlive.com to find out more.
I hope you enjoy this issue!
Iona Everson
Group Managing Editor
Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at www.pmlive.com/register
THE TEAM
Editorial:
Group Managing Editor
Iona Everson
Deputy Editor
Emily Kimber
Studio:
Executive Director
Karl Equi
Sales:
Business Director
Tara Lovegrove
EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals
PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201
CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com
Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2024 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW